DUX4-r exerts a neomorphic activity that depends on GTF2I in acute lymphoblastic leukemia is a research paper published in Science Advances (2023). On theSindex it has a DataRank of 0. It has been cited 2 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NCI NIH HHS
Grant: R21 CA249378
European Commission
Grant: 841957
Inhibitor of DUX4-IGH to Erase Acute lymphoblastic Leukaemia
National Institutes of Health
Grant: 1R21CA249378-01
Regulation of human endogenous retroviruses in the context of cancer immunotherapy
European Commission
Grant: 823839
European Proteomics Infrastructure Consortium providing Access
FWCI
0.48
Citation Percentile
0.7%
Influential Citations
1
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals